No association between apolipoprotein E alleles and olivopontocerebellar atrophy

Journal of the Neurological Sciences

Volumn 158, Issue 1, 1998, Pages 110-112

  Toji, Hiromasa ^a   Kawakami, Hideshi ^a   Kawarai, Toshitaka ^a   Nakayama, Takayasu ^a   Komure, Osamu ^b   Kuno, Sadako ^b   Nakamura, Shigenobu ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b Dept Neurol Utano Natl H   (Japan)

Author keywords

Apolipoprotein E; Dementia; Olivopontocerebellar atrophy

Indexed keywords

APOLIPOPROTEIN E4; DNA;

ALLELISM; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOPROTEIN METABOLISM; OLIVOPONTOCEREBELLAR ATROPHY; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION;

ALLELES; APOLIPOPROTEINS; APOLIPOPROTEINS D; DISEASE SUSCEPTIBILITY; GENOTYPE; HUMANS; MIDDLE AGED; NERVE TISSUE PROTEINS; OLIVOPONTOCEREBELLAR ATROPHIES;

EID: 0032507892     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00099-9     Document Type: Article

References (15)

1. Berciano J. Olivopontocerebellar atrophy. A review of 117 cases. J Neurol Sci. 53:1982;253-272.
2. Corder E.H., Saunders A.M., Risch N.J.et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genet. 7:1994;180-184.
3. Corder E.H., Saunders A.M., Strittmatter W.J.et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
4. Critchley M., Greenfield J.G. Olivopontocerebellar atrophy. Brain. 71:1948;343-364.
5. Galasko D., Saitoh T., Xia Y.et al. The apolipoprotein E allele ε4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology. 44:1994;1950-1951.
6. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha I. J Lipid Res. 31:1990;545-548.
7. Kawanishi C., Suzuki K., Odawara T.et al. Neuropathological evaluation and apolipoprotein E gene polymorphism analysis in diffuse Lewy body disease. J Neurol Sci. 136:1996;140-142.
8. Kish S.J., El-Awar M., Schut L.et al. Cognitive deficits in olivopontocerebellar atrophy: implications for the cholinergic hypothesis of Alzheimer's dementia. Ann Neurol. 24:1988;200-206.
9. Koller W.C., Glatt S.L., Hubble J.P.et al. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol. 37:1995;242-245.
10. Mui S., Rebeck G.W., McKenna-Yasek D.et al. Apolipoprotein E ε4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol. 38:1995;460-463.
11. Nitsch R.M., Blusztajn J.K., Doyle F.M.et al. Phospholipid metabolite levels are altered in cerebral cortex of patients with dominantly inherited olivopontocerebellar atrophy. Neurosci Lett. 161:1993;191-194.
12. Poirier J., Delisle M.-C., Quirion R.et al. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci USA. 92:1995;12260-12264.
13. Saunders A.M., Strittmatter W.J., Schmechel D.et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
14. Schmechel D.E., Saunders A.M., Strittmatter W.J.et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA. 90:1993;9649-9653.
15. Schneider J.A., Gearing M., Robbins R.S.et al. Apolipoprotein E genotype in diverse neurodegenerative disorders. Ann Neurol. 38:1995;131-135.